⌘K

Login Start Free

Home/Insiders/Adler Reid G.

AR

SEC Insider//CIK 0001924908

Adler Reid G.

CIK 00019249081 companySOUTH SAN FRANCISCO, CA

Transactions

11

Companies

1

Filings

10

CIK

0001924908

Recent Transactions

11 trades

Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2026-06-30$0.19/sh+36,818→ 60,868 total
Award
Vistagen Therapeutics, Inc.$VTGN
Incentive Stock Option (right to buy)
2026-04-07+18,753→ 18,753 total
Award
Vistagen Therapeutics, Inc.$VTGN
Non-Qualified Stock Option (right to buy)
2026-04-07+56,247→ 56,247 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2025-06-30$1.70/sh+7,541→ 24,050 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2025-06-23+100,000→ 100,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2024-06-28$2.96/sh+4,854→ 16,509 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Option (Right to Buy)
2024-06-24+170,000→ 170,000 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2023-12-29$1.72/sh+167→ 11,655 total
Award
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2023-06-30$1.59/sh+167→ 11,488 total
Purchase
Vistagen Therapeutics, Inc.$VTGN
Common Stock
2022-08-17$0.17/sh+300,000→ 334,629 total
Award
Vistagen Therapeutics, Inc.$VTGN
Stock Options (right to buy)
2022-05-02+200,000→ 200,000 total

Companies

1

Vistagen Therapeutics, Inc.
Chief Legal Officer
$VTGN

Recent Filings

10

Address

C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov